Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intra-Osseous Co-Transplant of UCB and hMSC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE2
Quantitative MRI for Myelofibrosis
- Status
- RECRUITING
- Phase
- N/A
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Status
- TERMINATED
- Phase
- NA
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
- Status
- COMPLETED
- Phase
- N/A
Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
- Status
- COMPLETED
- Phase
- NA
A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE1
Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2